Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-26T19:42:10.329Z Has data issue: false hasContentIssue false

Gastrin, Nitric Oxide Synthase and their Role in Ulceration and Distention of Stomach after Cisplatin and Taxol Treatment

Published online by Cambridge University Press:  02 July 2020

Ying Wang
Affiliation:
Department of Zoology, Michigan State University, East Lansing, MI48824-1115
Surinder K. Aggarwal
Affiliation:
Department of Zoology, Michigan State University, East Lansing, MI48824-1115
Get access

Extract

Cisplatin, a potent broad spectrum anti-cancer agent, has been proven effective in the treatment of different kinds of cancer, such as bladder, lung, ovarian, head, neck, etc.. Drawbacks of this chemotherapeutic drug are its toxic side-effects, which include severe nausea, vomiting, stomach distention and peptic ulcer.

Taxol is another effective chemotherapeutic agent which is usually used in conjection with cisplatin. It has demonstrated impressive activity in breast, ovarian, lung, and head and neck cancers. The toxic side-effects include nausea, vomiting, nephrotoxicity. The mechanism of these gastrointestinal side-effects are still unclear. Because of the role of NOS and gastrin on stomach smooth muscle contractility and gastroprotection, these were studied in the rats after cisplatin and taxol administration.

Wistar rats(100-150 g) were injected with cisplatin(9 mg/kg) and taxol(20 mg/kg) in five divided dosages over a period of 5 days. Rats were killed one day after the last injection. Rat stomach tissues were fixed in Bouin’s solution and processed for light microscopy.

Type
Pathology
Copyright
Copyright © Microscopy Society of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Aggarwal, -SK, San Antonio, -JD, et al.Cisplatin-induced peptic ulcers, vagotomy, adrenal and calcium modulation. Anti-Cancer Drugs,: 1994,5: 177193Google Scholar
2.Konturek, -SJ,Brzozowski, -T, et al.Role of endogenous gastrin in gastroprotection. Eur J Pharmaco,: 1995, 27: 203-12Google Scholar
3.Jarve, -RK, Aggarwal, -SK, Cisplatin-induced inhibition of the calcium-calmodulin complex, neuronal nitric oxide synthase activation and their role in stomach distention. Cancer Chemother Charmacol,: 1997, 39: 341348Google Scholar